IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy

Abstract Background Impact of interleukin 28B (IL28B) rs12979860 polymorphism on response to direct-acting antivirals agents in HCV genotype 4-infected patients is under investigation. Zinc may have an advantage in improvement of liver damage and treatment outcome. We aimed to evaluate IL28B polymor...

Cijeli opis

Bibliografski detalji

Glavni autori:	Abdelfattah M. Attallah, Dalia Omran, Mohamed A. Abdelrazek, Mohamed Hassany, Sameh Saif, Aza Farid, Riham El Essawey, Muhammad Abdel Ghaffar, Marwa Aabdelghany, Ayman Yosry
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2021-10-01
Serija:	Journal of Genetic Engineering and Biotechnology
Teme:	Direct-acting antiviral agents Hepatitis C virus Interleukin 28B Liver fibrosis Sustained virologic response
Online pristup:	https://doi.org/10.1186/s43141-021-00250-y
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!